June 15, 2010
Written By Julie Stachowiak, Ph.D.,
It looks like the time when oral MS drugs will be available is getting closer, maybe even measured in months. Clearly (and unfortunately), not all of us have the option of switching, since the oral candidates at this time (fingolimod and cladribine) are for relapsing-remitting multiple sclerosis.
However, for those of us that do have the option of switching from an injectible disease-modifying therapy for our MS, I pose the questions:
- Are you going to switch as soon as you can?
- Why or why not?
- What do you think your doctor will say?
*
*
****************************************************************
“Providing You with ‘MS Views and News’, is what we do“
Keep Informed and up–to–date with information concerning
Multiple Sclerosis when registered at
the MS Views and News website.
(This will take 20-25 seconds and will empower you
with informaton and learning)
Thank you for allowing me to help to keep you informed
****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews